Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)

Closed Posted

Opportunity number
PA-25-212
Agency
Applications due
Award size
Not on record

Opportunity facts

Assistance listings
20 more on GovTribe
Funding instrument
Grant
Categories
  • Education
  • Environment
  • Food and Nutrition
  • Health
  • Income Security and Social Services
Eligible applicants
  • Higher Education Inst. (Public)
Full announcement

Opportunity details come from Grants.gov. Updated .

About this opportunity

The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) are offering administrative supplement awards through the I-Corps at NIH program. The purpose is to provide active SBIR (NIH and CDC) and STTR Phase I (NIH only) grantees/awardees with access to instruction and mentoring to accelerate the translation of their technologies and validate a strategic business model through customer discovery. The program aims to help participants refine their commercialization plans and inform their overall commercialization strategies. Prospective applicants are strongly encouraged to contact program staff for more information prior to applying. The application deadline is January 31, 2025.

The I-Corps at NIH program provides three-member project teams with funding through administrative supplement awards. Award values are not specified, but the grants are intended to cover the entire duration of the I-Corps cohort program. The research and related activities are expected to be conducted at the facilities of the recipient organizations across the United States.

Synopsis

Through this I-Corps at NIH program Notice of Funding Opportunity (NOFO), NIH and CDC provide administrative supplement awards to active SBIR (NIH and CDC) and STTR Phase I (NIH only) grantees/awardees. The I-Corps at NIH mission is to empower entrepreneurs in developing and validating a strategic business model through diverse customer discovery in order to meet unmet clinical needs. I-Corps enables and accelerates the transformation of invention to impact SBIR and STTR Phase I awardees in a no-cost extension are eligible as long as, if selected, their no cost extension covers the entire duration of I-Corps at NIH cohort. The program provides three-member project teams with access to instruction and mentoring to accelerate the translation of technologies currently being developed with NIH and CDC SBIR and STTR funding. It is anticipated that outcomes for the I-Corps teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Prospective applicants are strongly encouraged to contact Scientific/Research staff for more information about the program before applying.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity